Invests in
Sectors:
Locations:
Min Investment:
$1,000,000.00Max Investment:
$50,000,000.00Target Investment:
$10,000,000.00
Skills
Education
Lists including Andre
Investments
Work Experience
2024
Board Member
2024
Forty-two years ago, a sisterly promise ignited a spark that would fuel a global crusade against breast cancer. Today that promise continues to prevail as the driving force behind Susan G. Komen’s unwavering quest for a future free from the grip of this deadly disease. In the pursuit of our goals, we’ve helped fuel research, unlocking the biology of breast cancer and discovering insights that propel us toward more effective risk reduction strategies, earlier detection methods and innovative treatments. This helped reduce breast cancer mortality by more than 42%. To date, we’ve invested nearly $3.6 billion in groundbreaking research, community health outreach, advocacy and programs in more than 60 countries. Due to investments in research, 19 new drugs for breast cancer were approved in the past decade, and Komen is proud to have been a catalyst for these discoveries. We stand firm in our promise to never give up on our vision of creating a world without breast cancer.
2024
Chief Investment Advisor
2024
We are a woman majority team, redefining the relationship between humans and AI. Founded on the belief that AI should partner with people rather than replace them, we create AI solutions that enhance human capabilities and foster meaningful collaboration. Our diverse team includes engineers, philosophers, behavioralists, linguists, artists, and MBAs. Our mission is to empower individuals and businesses with AI tools that augment human intelligence and creativity, envisioning a future where AI and humans collaborate seamlessly to achieve extraordinary outcomes.
Member Board of Directors
2023
PANO (the Pennsylvania Association of Nonprofit Organizations) is a statewide membership organization supporting the thousands of nonprofits that serve millions of people in the Commonwealth. While other associations cater to specific nonprofit trades, PANO is the only membership organization that supports Pennsylvania’s nonprofit sector as a collective whole. We support nonprofits through training, best practices, consultation and discount programs. We amplify their impact through research, public policy initiatives and advocacy. PANO is accredited by the Standards for Excellence Institute, signifying that the organization practices the highest level of ethics, accountability and transparency.
2022 - 2024
Chief Growth Officer
2022 - 2024
The Patient Access Network Foundation is a US-based non-profit 501 organization that works to help Americans pay for medical procedures. The organization was ranked #34 in Forbes' 2019 list of "top 100 US Charities", with private donations in 2019 totaling $434 million.
2019 - 2022
Venture Partner
2019 - 2022
CANCER FUND is an impact focused venture capital firm. CANCER FUND I, our first fund, is an impact investment fund helping early-stage companies move cancer innovations from the lab to patients.
2014 - 2019
Commercial Healthcare Business Advisor
2014 - 2019
Member of McKinsey & Company (Executive Member Panel). Providing thought leader expertise in the spaces of Healthcare, Med-Tech, Consumers Products and Chemicals. In addition, providing experiences in revenue/fundraising business development commercial infrastructure.
2014 - 2018
Managing Director
2014 - 2018
• Angel/LP/VC • Licensing Strategies/Investor Relations • Strategic Partnerships: PE/VC/Family Office (Capital Formation/Fundraising/Exit Strategy • Facilitation Mergers & Acquisitions • Corporate Strategy • Commercial Operations Strategies: Pricing, Profit Margin Management, Valuation Strategies • Value Proposition Infrastructure and Investor Attractiveness Strategy • Help with taking companies take to IPO status and/or acquisition. • Clients: BASF Services/Raw Materials, LUDIN MINING, MORGAN ADVANCE MATERIALS, JAGUAR/LAND ROVER
2011 - 2018
Founding Board Chair Emeritus
2011 - 2018
Previously, board chairman emeritus for ARTZ Philadelphia (Non-Profit Organization). ARTZ Philadelphia is an organization that links artists and cultural institutions to people living with dementia and their care partners. Influenced by science and sociology, ARTZ uses artistic and cultural experiences as keys to unlock creativity, create new memories, strengthen relationships, and replace fear with hope. ARTZ recognizes the wholeness that is inherent in each person, regardless of a diagnosis. We celebrate each person's capacity to fully participate in the journey of life. We believe that access to creative expression is essential to our human experience. Our Vision: ARTZ Philadelphia was founded on the belief that people living with dementia should be accorded the benefits of well-being and quality of life that others enjoy. We provide cultural and creative opportunities that turn that belief into reality. We are committed to supporting and celebrating people with dementia and their care partners as valued members of our wider creative community. Our Mission: Our purpose is to provide opportunities for self-expression and for the rebuilding of self-esteem and dignity to people with memory loss and those who care for them. We achieve this mission through research-based programs that connect people living with dementia and their care partners with artists and cultural organizations in creative community.
2008 - 2014
Chief Investment/Commercial Officer (Global Animal Healthcare/Welfare/ESG Organization)
2008 - 2014
Responsible for Global (Worldwide) Animal Welfare and Healthcare Impact Investment including: Developed partnership relationships in 12 countries that included supporting local agricultural and farming initiatives that included: Investing, Commercial Operations, Local Government Policy and ESG sustainment. • Led a team of 250 personal with 12 direct reports (Country Directors) • Identified and help to invest and secure investments for local farmers to help maintain healthy infrastructure for livestock. • Worked with and partnered with several global agencies (e.g., WHO) on animal health and proper poultry maintenance practices. • Built and implemented a farming market customer segmentation plan that achieved a 98% top line revenue growth with wholesale/distributor accounts for new product/services Closamectin Pour-On and achieved organizational budget of 700 million. • Designed and implemented a commercial sales operations strategy (for local farmers) that increased customer call penetration, frequency and sales performance of the country sales directors and their sales staffs. • Brought to company key sales management tools, such as pipeline/opportunity tracking, performance dashboard templates and “Buying Cycle” selling skill tool (helped to develop better efficiencies). • Along with Chairman developed pricing plan, marketing positioning/market research strategies and SFE strategies for various products which helped to increase new animal healthcare device products. • Developed/Designed commissions compensation and bonus structure for global sales force.
2006 - 2008
Global Head of Commercial Operations (BioPharm Group)
2006 - 2008
Built and led the entire infrastructure of the BioPharm sales operations department from ground level up. Results included: ·As operations head, instituted SFE tools for business development group and increased account development performance (before implementation 89% after implementation 119% ·Building and executing BD analytics, call planning, customer segmentation processes for 3 categories of business (Hemophilia-Oncology/ Woman’s Healthcare/ Growth Hormone). ·Built an entire business development training department that included best in class sales competency models, innovative e.learning and account management development curriculum ·Created a “Buying Cycle” sales strategy that helped the Hematology/Growth Hormone groups achieve above forecast (120%) consistently throughout my 2 year tenure. ·Collaborated with sister countries on implementing similar sales operations methods and initiatives